These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3262046)

  • 1. Toward a chronoimmunomodulation by cefodizime in multiple myeloma and chronic uremia.
    Carandente F; De Vecchi A; Halberg F; Cornélissen G; Dammacco F
    Chronobiologia; 1988; 15(1-2):61-85. PubMed ID: 3262046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A chronobiological approach to the effects of cefodizime on monocytic and granulocytic functions of patients with multiple myeloma.
    Carandente F; Dammacco F; Balsamo V
    Chronobiologia; 1991; 18(2-3):89-92. PubMed ID: 1760964
    [No Abstract]   [Full Text] [Related]  

  • 3. Cefodizime administration in healthy subjects: studies of natural killer cells, urinary hormones and electrolytes.
    Ventura MM; Romagnoli M; Santucci S; Sforza C; Gatti G; Carandente O
    Chronobiologia; 1988; 15(1-2):43-59. PubMed ID: 2970951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclic lysozyme administration as a tool for immunopotentiation in patients with multiple myeloma.
    Vacca A; Campobasso N; Iodice G; Ronco M; Dammacco F
    Chemioterapia; 1985 Apr; 4(2):147-55. PubMed ID: 3924421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cefodizime on peritoneal mononuclear- and polymorphonuclear-cell chemotaxis.
    Ustün H; Ersoy FF; Sezer T; Ozcan S; Bozcuk H; Yegin O; Balci M; Süleymanlar G; Yakupoglu G
    Adv Perit Dial; 1998; 14():154-7. PubMed ID: 10649715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronosynergistic effects of lighting schedule-shift and cefodizime on plasmacytoma growth and host survival time.
    Wu J; Sánchez de la Peña S; Halberg F; Cornélissen G; Wetterberg L; Halberg E; Lakatua D; Bingham C; Harvey J; Bazin H
    Chronobiologia; 1988; 15(1-2):105-28. PubMed ID: 3416672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefodizime: a new cephalosporin with apparent immune-stimulating properties in chronic renal failure.
    Vanholder R; Van Landschoot N; Dagrosa E; Ringoir S
    Nephrol Dial Transplant; 1988; 3(2):221-4. PubMed ID: 3140091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of cefodizime on phagocyte function in non-patient volunteers and patients with chronic renal failure. In vitro and ex vivo studies.
    McCafferty AC; McGregor E; Jones M; Henderson IS; Cree IA
    Int J Clin Lab Res; 1996; 26(4):229-35. PubMed ID: 9007612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cefodizime (HR 221) on immunological defects induced by surgical stress.
    Auteri A; Pasqui AL; Bruni F; Saletti M; Mazza S; Di Renzo M; Maggiore D; Di Perri T
    Drugs Exp Clin Res; 1991; 17(12):555-61. PubMed ID: 1841048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cefodizime on non-specific immune functions in patients with multiple myeloma.
    Dammacco F; Benvestito S
    Infection; 1992; 20 Suppl 1():S64-6. PubMed ID: 1526682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of cefodizime on the reagibility of human leukocytes.
    Limbert M; Müllner H; Shah PM
    Infection; 1992; 20 Suppl 1():S48-50. PubMed ID: 1388140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-cell activation modified by parathyroid hormone (PTH) in patients with end-stage renal disease.
    Kaneko T; Osono E; Hayama N; Lino Y; Terashi A
    Clin Nephrol; 1997 Dec; 48(6):353-8. PubMed ID: 9438093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of cefodizime on chemotaxis and the respiratory burst in neutrophils from diabetics.
    Shaio MF; Chang FY
    J Antimicrob Chemother; 1990 Jul; 26(1):55-9. PubMed ID: 2211447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bone marrow T-lymphocyte subpopulations in patients with multiple myeloma].
    Rizzo M; Meli C; Bonanno M; Maccarrone S; Guglielmo P
    Boll Soc Ital Biol Sper; 1981 Mar; 57(6):678-84. PubMed ID: 6973996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cefodizime on parameters of cell-mediated immunity in vitro.
    Mallmann P; Brühl P; Dagrosa EE; Reeves A
    Arzneimittelforschung; 1992 Apr; 42(4):567-70. PubMed ID: 1642684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplenic and transtumoral in vivo immunostimulation: effect on cellular immunity parameters.
    Boura P; Kountouras J; Lygidakis NJ; Safioleas M; Aphinives P
    Hepatogastroenterology; 1999; 46(26):799-803. PubMed ID: 10370616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circadian rhythm of sister chromatid exchanges in human chromosomes.
    Goyanes V; Cupeiro A; Campos A; Lage B; Garcia Alonso L; Cornélissen G; Halberg F
    In Vivo; 1995; 9(4):413-5. PubMed ID: 8555443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different immune reconstitution in multiple myeloma, chronic myeloid leukemia and acute myeloid leukemia patients after allogeneic transplantation of peripheral blood stem cells.
    Rondelli D; Re F; Bandini G; Raspadori D; Arpinati M; Senese B; Stanzani M; Bonifazi F; Falcioni S; Chirumbolo G; Tura S
    Bone Marrow Transplant; 2000 Dec; 26(12):1325-31. PubMed ID: 11223973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cefotaxime and cefodizime on human granulocyte functions in vitro.
    Labro MT; Babin-Chevaye C; Hakim J
    J Antimicrob Chemother; 1986 Aug; 18(2):233-7. PubMed ID: 3019985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies.
    Cao TM; Kusnierz-Glaz C; Valone F; Stockerl-Goldstein KE; Hu WW; Johnston L; Blume KG; Strober S; Negrin RS
    Cancer; 2001 Jun; 91(12):2205-13. PubMed ID: 11413507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.